Cipla Q2 Net Profit Rises 15% YoY to ₹1,303 Crore.

by: adminPosted on:

Cipla Q2 Net Profit Rises 15% YoY to ₹1,303 Crore.

Cipla Limited, a leading global pharmaceutical company, has reported a strong performance for the second quarter of the financial year 2024-25 (Q2 FY25).

Cipla reported a 15% year-on-year increase in its net profit for the second quarter, reaching ₹1,303 crore. This growth can be attributed to strong operational performance and cost management. Key factors contributing to this rise include robust revenue from its respiratory and chronic therapy segment.

  • Net Profit: The company’s consolidated net profit surged by 15% year-on-year (YoY) to Rs 1,303 crore in Q2 FY25.
  • margin Expansion: Cipla’s EBITDA margin expanded by 10 basis points YoY to 22.3% in Q2 FY25.